Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.

MLA

Gootjes, Elske C., et al. “Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.” The Oncologist, vol. 25, no. 8, Aug. 2020, pp. e1195–201. EBSCOhost, https://doi.org/10.1634/theoncologist.2019-0693.

APA

Gootjes, E. C., van der Stok, E. P., Buffart, T. E., Bakkerus, L., Labots, M., Zonderhuis, B. M., Tuynman, J. B., Meijerink, M. R., van de Ven, P. M., Haasbeek, C. J. A., Ten Tije, A. J., de Groot, J.-W. B., Hendriks, M. P., van Meerten, E., Nuyttens, J. J. M. E., Grunhagen, D. J., Verhoef, C., & Verheul, H. M. W. (2020). Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer. The Oncologist, 25(8), e1195–e1201. https://doi.org/10.1634/theoncologist.2019-0693

Chicago

Gootjes, Elske C, Eric P van der Stok, Tineke E Buffart, Lotte Bakkerus, Mariette Labots, Barbara M Zonderhuis, Jurriaan B Tuynman, et al. 2020. “Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.” The Oncologist 25 (8): e1195–1201. doi:10.1634/theoncologist.2019-0693.